157. Sturge-Weber syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 10 / Drugs : 13 - (DrugBank : 4) / Drug target genes : 5 - Drug target pathways : 63
Sturge-Weber syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
157 | Sturge-Weber syndrome |
158 | Tuberous sclerosis |
6 | Parkinson disease |
46 | Malignant rheumatoid arthritis |
96 | Crohn disease |
193 | Prader-Willi syndrome |
2 | Amyotrophic lateral sclerosis |
13 | Multiple sclerosis/Neuromyelitis optica |
278 | Huge lymphatic malformation with cervicofacial lesion |
36 | Epidermolysis bullosa |
17 | Multiple system atrophy |
226 | Interstitial cystitis with Hunners ulcer |
85 | Idiopathic interstitial pneumonia |
86 | Pulmonary arterial hypertension |
57 | Idiopathic dilated cardiomyopathy |
169 | Menkes disease |
170 | Occipital horn syndrome |
167 | Marfan syndrome |
192 | Cockayne syndrome |
277 | Lymphangiomatosis |
281 | Klippel-Trenaunay-Weber syndrome |
111 | Congenital myopathy |
137 | Focal cortical dysplasia |